301 related articles for article (PubMed ID: 17262048)
1. Caspofungin for the treatment of azole resistant candidemia in a premature infant.
Smith PB; Steinbach WJ; Cotten CM; Schell WA; Perfect JR; Walsh TJ; Benjamin DK
J Perinatol; 2007 Feb; 27(2):127-9. PubMed ID: 17262048
[TBL] [Abstract][Full Text] [Related]
2. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Manfredi R; Sabbatani S
Scand J Infect Dis; 2006; 38(10):950-1. PubMed ID: 17008248
[TBL] [Abstract][Full Text] [Related]
3. Successful caspofungin treatment of persistent candidemia in extreme prematurity at 23 and 24 weeks' gestation.
Jeon GW; Sin JB
J Formos Med Assoc; 2014 Mar; 113(3):191-4. PubMed ID: 24534016
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole for candidosis: an important addition?
Graybill JR
Lancet; 2005 Oct 22-28; 366(9495):1413-4. PubMed ID: 16243074
[No Abstract] [Full Text] [Related]
5. Caspofungin therapy of neonates with invasive candidiasis.
Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
[TBL] [Abstract][Full Text] [Related]
6. Caspofungin for refractory candidemia in neonates.
Manzar S; Kamat M; Pyati S
Pediatr Infect Dis J; 2006 Mar; 25(3):282-3. PubMed ID: 16511405
[No Abstract] [Full Text] [Related]
7. Antifungal resistance: the clinical front.
Perfect JR
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
[TBL] [Abstract][Full Text] [Related]
8. Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate.
Yalaz M; Akisu M; Hilmioglu S; Calkavur S; Cakmak B; Kultursay N
Mycoses; 2006 May; 49(3):242-5. PubMed ID: 16681818
[TBL] [Abstract][Full Text] [Related]
9. Experience with caspofungin in the treatment of persistent fungemia in neonates.
Natarajan G; Lulic-Botica M; Rongkavilit C; Pappas A; Bedard M
J Perinatol; 2005 Dec; 25(12):770-7. PubMed ID: 16222348
[TBL] [Abstract][Full Text] [Related]
10. Combination antifungal therapy with voriconazole for persistent candidemia in very low birth weight neonates.
Turan O; Ergenekon E; Hirfanoğlu IM; Onal EE; Baş VN; Türkyilmaz C; Koç E; Atalay Y
Turk J Pediatr; 2011; 53(1):19-26. PubMed ID: 21534335
[TBL] [Abstract][Full Text] [Related]
11. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
Santos RP; Sánchez PJ; Mejias A; Benjamin DK; Walsh TJ; Patel S; Jafri HS
Pediatr Infect Dis J; 2007 Apr; 26(4):364-6. PubMed ID: 17414408
[TBL] [Abstract][Full Text] [Related]
12. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
[TBL] [Abstract][Full Text] [Related]
13. Acquired resistance to echinocandins in Candida albicans: case report and review.
Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
[TBL] [Abstract][Full Text] [Related]
14. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
[TBL] [Abstract][Full Text] [Related]
15. Antifungal pharmacotherapy for neonatal candidiasis.
Bliss JM; Wellington M; Gigliotti F
Semin Perinatol; 2003 Oct; 27(5):365-74. PubMed ID: 14626500
[TBL] [Abstract][Full Text] [Related]
16. Disseminated candidemia refractory to caspofungin therapy in an infant with extremely low birth weight.
Li MJ; Hsueh PR; Lu CY; Chou HC; Lee PI; Chang LY; Huang LM
J Formos Med Assoc; 2012 Jan; 111(1):46-50. PubMed ID: 22333013
[TBL] [Abstract][Full Text] [Related]
17. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
18. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
Shuford JA; Piper KE; Steckelberg JM; Patel R
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):277-81. PubMed ID: 17141454
[TBL] [Abstract][Full Text] [Related]
19. [New antifungal agents: voriconazole and caspofungin].
Dupont B
Arch Pediatr; 2003 Dec; 10 Suppl 5():592s-598s. PubMed ID: 15022787
[TBL] [Abstract][Full Text] [Related]
20. The effects of caspofungin and voriconazole in experimental Candida endophthalmitis.
Kusbeci T; Avci B; Cetinkaya Z; Ozturk F; Yavas G; Ermis SS; Inan UU
Curr Eye Res; 2007 Jan; 32(1):57-64. PubMed ID: 17364736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]